Drug-coated balloon

Original Contribution

Retrospective Review of Directional Atherectomy and Drug-Coated Balloon Use in a PAD Safety-Net Population

04/01/2023

Shea E. Hogan, MD, MSCS^1-3; Matthew Holland, MD^1,2; Joseph Burke, MD^1,2; Paisley Johnson, MD^1,2; Demetria McNeal, MD⁴; Lisa Cicutto, MD⁵; Mark Nehler, MD⁶; Pamela N. Peterson, MD, MSPH^1,2

Shea E. Hogan, MD, MSCS1-3; Matthew H...

The authors retrospectively reviewed outcomes of patients with peripheral artery disease who underwent directional atherectomy and drug-coated balloon during lower extremity revascularization.

The authors retrospectively...

04/01/2023

Journal of Invasive Cardiology

Murasato Quadrifurcation Lesion Figure 1

Clinical Images

Stentless Treatment for a Left Main Quadrifurcation Lesion

12/01/2022

Yoshinobu Murasato, MD, PhD; Soichiro Omura, MD; Shoko Fukuda, MD

Yoshinobu Murasato, MD, PhD; Soichir...

A 69-year-old man underwent coronary intervention for stenosis in the left main (LM) quadrifurcation lesion with SYNTAX score 23 (SYNTAX II score: coronary intervention 27.5, bypass surgery 33.5) 1 week after primary stenting in the right...

A 69-year-old man underwent...

12/01/2022

Journal of Invasive Cardiology

Original Research

Clinical Performance of a Paclitaxel Drug-Coated Balloon in Real-World Percutaneous Coronary Intervention Practice: The PEARL Registry

06/01/2022

Selina Vlieger, MSc¹; Jin M. Cheng, MD, PhD²; Rohit M. Oemrawsingh, MD, PhD¹; Auke P.J.D. Weevers, MD¹; Jawed Polad, MD³; Ben Gho, MD, PhD⁴; Martijn Meuwissen, MD, PhD²; Peter den Heijer, MD, PhD²; Eric Boersma, PhD⁵; Alexander J.J. IJsselmuiden, MD, PhD²

Selina Vlieger, MSc1; Jin M. Cheng, ...

Randomized controlled trials for in-stent restenosis (ISR) and de novo lesions in small-diameter vessels have shown promising results, but data on DCB use in real-world practice are still scarce. The aim of the PEARL (Paclitaxel-Eluting...

Randomized controlled trials for...

06/01/2022

Journal of Invasive Cardiology

Giannopoulos Drug-Eluting Stent Figure 1

Original Contribution

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

06/01/2022

Stefanos Giannopoulos, MD¹; Eric A. Secemsky, MD²; Peter A. Schneider, MD³; Ehrin J. Armstrong, MD¹

Stefanos Giannopoulos, MD1; Eric A. ...

The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...

The application of 2 distinct...

06/01/2022

Journal of Invasive Cardiology

Original Contribution

Two-Year Clinical Outcomes of the REVELATION Study: Sustained Safety and Feasibility of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent in Acute Myocardial Infarction

01/03/2022

Sander R. Niehe, MD; Nicola S. Vos, MD, PhD; René J. Van Der Schaaf, MD, PhD; Giovanni Amoroso, MD, PhD; Jean-Paul R. Herrman, MD, PhD; Mark S. Patterson, MD, PhD; Ton Slagboom, MD; Maarten A. Vink, MD, PhD

Sander R. Niehe, MD; Nicola S. Vos, M...

The randomized REVELATION trial showed that in the setting of STEMI, a drug-coated balloon strategy was non-inferior to a drug-eluting stent strategy in terms of fractional flow reserve assessed at 9 months. The aim of the present study is to...

The randomized REVELATION trial...

01/03/2022

Journal of Invasive Cardiology

Original Contribution

Rationale and Design of the IN.PACT BTK Randomized Pilot Study: A Paclitaxel Drug-Coated Balloon vs Standard Percutaneous Transluminal Angioplasty for Infrapopliteal Chronic Total Occlusions

06/08/2021

Antonio Micari, MD, PhD¹; Jeffrey J. Popma, MD²; Francesco Liistro, MD³

Antonio Micari, MD, PhD1; Jeffrey J....

This is a pilot feasibility study and the objective is to evaluate the safety and effectiveness of the investigational device, IN.PACT 014 drug-coated balloon, compared with standard PTA in patients with CLI with CTOs of BTK arteries.

This is a pilot feasibility...

06/08/2021

Cath Lab Digest

Paclitaxel Drug-Coated Balloon After Bare-Metal Stent Implantation, an Alternative Treatment to Drug-Eluting Stent in High Bleeding Risk Patients (The Panelux Trial)

03/28/2019

Jerome Roncalli, MD, PhD¹; Matthieu Godin, MD²; Kamel Boughalem, MD³; John Shayne, MD⁴; Christophe Piot, MD, PhD⁵; Bruno Huret, MD⁶; Loic Belle, MD⁷; Guillaume Cayla, MD, PhD⁸; Benjamin Faurie, MD⁹; Max Amor, MD¹⁰; Bernard Karsenty, MD¹¹; Florence Leclercq, MD, PhD¹²

Jerome Roncalli, MD, PhD1; Matthieu ...

Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...

Prolonged dual-antiplatelet...

03/28/2019

Journal of Invasive Cardiology